PT Medikaloka Hermina Tbk

Equities

HEAL

ID1000143100

Healthcare Facilities & Services

End-of-day quote INDONESIA S.E. Other stock markets 23:00:00 16/05/2024 BST			5-day change	1st Jan Change
1,335 ^IDR	-0.74%		-1.84%	-10.40%

04-26	PT Medikaloka Hermina Tbk Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-28	PT Medikaloka Hermina Tbk Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Quadria Capital Fund II LP managed by Quadria Capital acquired an unknown minority stake in PT Medikaloka Hermina Tbk.

March 21, 2021

Quadria Capital Fund II LP managed by Quadria Capital acquired an unknown minority stake in PT Medikaloka Hermina Tbk (IDX:HEAL) on March 22, 2021. Quadria Capital Fund II LP managed by Quadria Capital completed the acquisition of an unknown minority stake in PT Medikaloka Hermina Tbk (IDX:HEAL) on March 22, 2021.

Latest news about PT Medikaloka Hermina Tbk

PT Medikaloka Hermina Tbk Reports Earnings Results for the First Quarter Ended March 31, 2024	04-26	CI
PT Medikaloka Hermina Tbk Reports Earnings Results for the Full Year Ended December 31, 2023	03-27	CI
PT Medikaloka Hermina Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023	18/10/23	CI
Indonesia consortium invests $1.3 bln in new capital	22/09/23	RE
Nomura Starts Medikaloka Hermina at Buy With IDR1,980 Price Target	22/08/23	MT
PT Medikaloka Hermina Tbk Reports Earnings Results for the Half Year Ended June 30, 2023	02/08/23	CI
Property firm Ciputra to build houses, hotel in Indonesia's new capital	10/07/23	RE
Hospital chain Hermina to invest in Indonesia's planned new capital	21/06/23	RE
PT Medikaloka Hermina Tbk Reports Earnings Results for the First Quarter Ended March 31, 2023	24/04/23	CI
PT Medikaloka Hermina Tbk Reports Earnings Results for the Full Year Ended December 31, 2022	30/03/23	CI
PT Medikaloka Hermina Tbk Reports Earnings Results for the Nine Months Ended September 30, 2022	04/11/22	CI
Indonesia to offer tax holiday to companies investing in new capital	19/10/22	RE
PT Medikaloka Hermina Tbk Reports Earnings Results for the Half Year Ended June 30, 2022	07/08/22	CI
PT Medikaloka Hermina Tbk Reports Earnings Results for the First Quarter Ended March 31, 2022	30/05/22	CI
PT Medikaloka Hermina Tbk Reports Earnings Results for the Full Year Ended December 31, 2021	31/03/22	CI
PT Medikaloka Hermina Tbk announces an Equity Buyback for 80,000,000 shares, for IDR 116,000 million.	16/02/22	CI
PT Medikaloka Hermina Tbk authorizes a Buyback Plan.	14/02/22	CI
PT Medikaloka Hermina Tbk Reports Earnings Results for the Nine Months Ended September 30, 2021	04/11/21	CI
PT Medikaloka Hermina Tbk(IDX:HEAL) added to S&P Global BMI Index	20/09/21	CI
PT Medikaloka Hermina Tbk Announces Earnings Results for the Half Year Ended June 30, 2021	30/07/21	CI
PT Medikaloka Hermina Tbk Reports Earnings Results for the First Quarter Ended March 31, 2021	22/06/21	CI
PT MEDIKALOKA HERMINA TBK : Nomura Adjusts Medikaloka Hermina's Price Target to 5,550 Indonesian Rupiahs From 5,200 Indonesian Rupiahs, Keeps at Buy	18/06/21	MT
Pt Medikaloka Hermina Tbk Reports Earnings Results for the Full Year Ended December 31, 2020	21/05/21	CI
Quadria Capital Fund II LP managed by Quadria Capital acquired an unknown minority stake in PT Medikaloka Hermina Tbk.	21/03/21	CI
PT Medikaloka Hermina Tbk 's Equity Buyback announced on November 16, 2020 has expired,	14/02/21	CI

Chart PT Medikaloka Hermina Tbk

Duration

Period

More charts

Company Profile

PT Medikaloka Hermina Tbk is an Indonesia-based company, which is engaged in offering general hospital services. The Company is focused on providing services for BPJS patients to support government program in Indonesia. The Companyâs services include hospitals, specialties, and featured services. The Companyâs hospitals include Hermina Arcamanik, Hermina Balikpapan, Hermina Banyumanik, Hermina Bekasi, Hermina Bitung, Hermina Bogor, Hermina Ciledug, Hermina Cilegon and Hermina Ciputat. In specialties service, the Company provides anatomical pathology, andrology, anesthesiology, cardiology, clinical microbiology, clinical pathology, dentistry, dermatology and venereology, dietetics, emergency medicine, forensic and medicolegal, internal medicine, medical acupuncture, neurology, and surgery. Its subsidiaries include PT Medikaloka Internusa (M Internusa), PT Medikaloka Sejahtera (M Sejahtera), PT Medikaloka Husada (M Husada), PT Medikaloka Daan Mogot and PT Medikaloka Pasteur (M Pasteur).

Sector

Healthcare Facilities & Services

Calendar

04/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for PT Medikaloka Hermina Tbk

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1,335 IDR

Average target price

1,693 IDR

Spread / Average Target

+26.83%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
PT MEDIKALOKA HERMINA TBK	-10.40%	1.25B
HCA HEALTHCARE, INC.	+19.28%	84.56B
CVS HEALTH CORPORATION	-26.95%	72.41B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+4.65%	27.75B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-7.35%	17.75B
QUEST DIAGNOSTICS INCORPORATED	+4.69%	16.03B
REDE D'OR SÃO LUIZ S.A.	+8.14%	13.72B
NATERA, INC.	+69.96%	13.07B
FRESENIUS MEDICAL CARE AG	+6.59%	12.91B
TENET HEALTHCARE CORPORATION	+70.00%	12.55B

Other Healthcare Facilities & Services